US FDA Panel Backs Pfizer Inc. (JOBS) Osteoporosis Drug

September 9, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ROCKVILLE, Md., Sept 8 (Reuters) - A Pfizer Inc drug rejected by U.S. regulators three years ago won support from an expert advisory panel on Monday for treating women with the bone-thinning disease osteoporosis.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Pfizer Food and Drug Administration (FDA)